Full-Time

Business Development Specialist

Neuro Rehab

Deadline 6/18/27
BrightSpring Health Services

BrightSpring Health Services

10,001+ employees

Home-based health services and pharmacy solutions

Compensation Overview

$70k - $85k/yr

+ Uncapped compensation plan

Arroyo Grande, CA, USA + 3 more

More locations: Grover Beach, CA, USA | San Luis Obispo, CA, USA | Pismo Beach, CA, USA

In Person

Travel is required for approximately 25–75% of the role.

Category
Business & Strategy (1)
Required Skills
Marketing

Get referred to BrightSpring Health Services

See people who can refer or advise you

Requirements
  • A minimum of 5 years of brand development experience, 5 years of sales and profit building in a management position, and a proven successful sales track record are required.
  • Neurorehabilitation licensed clinicians, including physical, occupational, speech, and recreational therapists and social workers, may be considered in lieu of brand development and sales experience.
  • Effective communication skills, professionalism, and customer focus are required.
  • Executive-level knowledge of business development and strategic planning is required.
  • The candidate must be self-motivated and able to think creatively.
  • The role requires 25–75% travel.
Responsibilities
  • Perform business development initiatives, including calling on potential new key accounts in the healthcare field.
  • Sustain a record of high achievement in business development and renewed business, evidenced by quarterly and annual growth of new referrals.
  • Speak directly with new and existing healthcare clients to explain service features and benefits based on client needs.
  • Develop and implement account-specific marketing approaches for each referral source, observe and document sales trends and competitor activities, and evaluate market conditions.
  • Identify and prioritize high-dollar and high-volume accounts and, with the Executive Director and Director of Business Development, prepare annual sales and marketing plans; implement approved plans and evaluate and update them monthly.
  • Visit and contact potential clients, including hospitals, payers, families, and physicians, to promote programs, and organize and coordinate local specialized marketing events with the Executive Director to educate consumers about programs.
  • Attend relevant industry trade shows and conferences to promote company services and prepare literature and flyers for specific customer groups as needed.
  • Provide timely updates to the company database with account contacts and ensure pre-established contact-frequency criteria are met.
  • Input and track account information and marketing activity and complete weekly, monthly, and quarterly reports in the specified format; keep current on industry trends and competitive activity and update information as needed.
  • Complete payer pipeline and account information projects as required.
  • Collaborate with operational and clinical team members to ensure the best outcomes for patients.
  • Participate in weekly sales team calls and bi-weekly coaching calls as directed by the Director of Business Development.
  • Participate in special projects and perform other duties assigned by the Director of Business Development.
Desired Qualifications
  • Healthcare sales experience in home health, rehabilitation, acute, or post-acute settings is preferred.
  • An established healthcare network in San Luis Obispo, Grover Beach, Arroyo Grande, Templeton, and the surrounding region is preferred.
  • Experience in rehabilitation services, health or home care, human services, pharmacy, or other medical outside sales is preferred.
BrightSpring Health Services

BrightSpring Health Services

View

BrightSpring Health Services delivers home and community-based health services for people with complex or chronic needs, organized into two segments: Pharmacy and Provider. The Pharmacy segment provides specialty, infusion, and community pharmacy services to patients with complex conditions. The Provider segment offers behavioral health, home health, hospice care, and services for individuals with intellectual and developmental disabilities. The company runs an integrated care model through a network of pharmacies and providers to support a continuum of care that includes clinical services, care coordination, and in-home support. Revenue comes from Medicare, Medicaid, and private insurance, reflecting reimbursement across public and private payers. The goal is to coordinate pharmacy and in-home health services to improve access, continuity, and outcomes for patients and to serve managed care organizations with a complete care solution.

Company Size

10,001+

Company Stage

Post IPO Equity

Headquarters

Louisville, Kentucky

Founded

1974

Get referred to BrightSpring Health Services

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 23% to $3.87 billion, with EBITDA up 44%.
  • Management raised 2026 EBITDA guidance to $820 million–$845 million on July 31, 2026.
  • Leverage fell to 2.15x, and S&P and Moody’s upgraded BrightSpring’s credit.

What critics are saying

  • IRA pricing cuts reduced Home and Community Pharmacy 8% in Q2 2026.
  • Management expects roughly $200 million 2026 IRA pressure, crushing pharmacy margin leverage.
  • PharMerica’s breach settlement and security spending drain cash during Amedisys integration.

What makes BrightSpring Health Services unique

  • BrightSpring combines specialty pharmacy with home-based provider services across complex chronic care.
  • Its 2026 portfolio reached 153 ultra-narrow drugs, strengthening limited-distribution access advantages.
  • Amedisys and LHC branches deepen BrightSpring’s local density in home health and hospice.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-10%

1 year growth

-10%

2 year growth

-10%
Yahoo Finance
Aug 20th, 2026
BrightSpring Health Services posts 23.9% revenue growth as Solventum and Inspire Medical face headwinds

BrightSpring Health Services stands out as a strong long-term healthcare investment, whilst Solventum and Inspire Medical Systems face headwinds, according to recent analysis. Healthcare stocks have surged 27.5% over the past six months, outperforming the S&P 500 by 16.2 percentage points. However, increased venture capital has intensified competition across the sector. BrightSpring, which provides home health care, hospice, and pharmacy services, has achieved 23.9% annual revenue growth over the past two years. Analysts forecast 14.1% revenue growth for the next 12 months. Conversely, Solventum faces weak demand with flat revenue expected, whilst its free cash flow margin has declined 18.2 percentage points over five years. Inspire Medical Systems confronts a forecasted revenue decline of 3.5% for the upcoming year.

Yahoo Finance
Aug 18th, 2026
Two profitable stocks with solid fundamentals and one to ignore

Two companies leverage profitability to outpace competitors, whilst another faces headwinds, according to StockStory's analysis. Primoris, which builds and maintains infrastructure in utility, energy, and civil construction sectors, struggles with a low gross margin of 10.3% reflecting high production costs. The company has seen falling earnings per share over two years and weak free cash flow margin of 2.2% over five years. BrightSpring Health Services, offering home health care and pharmacy services, has posted 23.9% annual revenue growth over two years. Its revenue base of $14.37 billion provides economies of scale. Pfizer's massive $63.7 billion revenue base gives it significant negotiating power. The pharmaceutical giant's adjusted operating margin expanded by 18.5 percentage points over two years, whilst delivering a 17.5% return on capital.

Yahoo Finance
Aug 9th, 2026
BrightSpring Health Services beats Q2 expectations with 23% revenue growth to $3.87B

BrightSpring Health Services exceeded Wall Street expectations in Q2, delivering revenue of $3.87 billion and adjusted earnings per share of $0.45, beating analyst estimates by 5.9% and 13% respectively. The company's Specialty and Infusion pharmacy business drove growth, with revenue up 30% and script growth of 31% year-over-year. CEO Jon Rousseau attributed the performance to new limited distribution drug launches and broad-based volume growth. However, segments like Home and Community Pharmacy faced challenges from customer exits and regulatory headwinds. The company raised its full-year revenue guidance to $15.26 billion at the midpoint, up 1.9% from previous guidance. Operating margin improved to 3.4%, compared to 1.5% in the prior-year quarter. Despite the strong results, the market reacted negatively, reflecting concerns about underlying business headwinds.

Yahoo Finance
Aug 6th, 2026
Micron leads 3 profitable stocks with strong net income ratios smart investors are buying

Micron Technology, BrightSpring Health Services, and Custom Truck One Source have emerged as standout profitable stocks based on strong net income ratios and growth prospects. The selection criteria included a Zacks Rank of #1, trailing 12-month sales and net income growth exceeding industry averages, and a net income ratio higher than the industry standard. Micron Technology, a global memory and storage provider, shows particularly impressive metrics with a 12-month net profit margin of 55.9%. The company's expected earnings growth rate for the current year stands at 791%. The screening process, using the Zacks Research Wizard, filtered more than 7,685 stocks down to just 13 that met all criteria. The net income ratio helps investors assess a company's ability to cover both operating and non-operating expenses with revenues.

Yahoo Finance
Aug 1st, 2026
BrightSpring Health Services shares drop 17.5% despite strong Q2 results and raised guidance

BrightSpring Health Services shares fell 17.5% after reporting second-quarter results, despite beating expectations. The healthcare services provider posted revenue of $3.87 billion, up 23% year-on-year, whilst non-GAAP profit reached $0.45 per share, exceeding forecasts. The company also raised its full-year guidance. However, investors responded negatively in what appeared to be a "sell-the-news" reaction. The sell-off may stem from valuation concerns and stagnant profit margins despite rising sales, raising questions about the company's cost structure. The stock has experienced 18 movements greater than 5% over the past year. At $59.71 per share, BrightSpring trades 18.1% below its 52-week high of $72.91 from July, though it remains up 55.5% year-to-date.